3 withdrawn, 2 active not recruiting, 2 completed. 4 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 2, Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Malignant Neoplasms of Male Genital Organs: new trials by email Literature Review of Malignant Neoplasms of Male Genital Organs trials Research Report on Malignant Neoplasms of Male Genital Organs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 18 | 2018-07-10 | 2026-04-16 |
| Neuromuscular Blockade on Shoulder Pain of Elderly Deep Neuromuscular Blockade (NMB), Moderate Neuromuscular Blockade (NMB), Sugammadex - Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs | Phase 4 | Completed | M.D. Anderson Cancer Center | 100 | 2017-11-17 | 2020-11-25 |
| Selumetinib and Olaparib in Solid Tumors Selumetinib, Olaparib - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 90 | 2017-08-04 | 2026-10-13 |
| Neoadjuvant Listeria or Daratumumab in Prostate Cancer Daratumumab - Malignant Neoplasms of Male Genital Organs, Prostate Cancer | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2017-03-01 | 2024-05-03 | |
| Lenvatinib and Capecitabine in Patients With Advanced Malignancies Lenvatinib, Capecitabine - Advanced Cancer, Malignant Neoplasm of Breast | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-12-01 | 2017-06-26 | |
| Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies Alisertib, TAK-228 - Malignant Neoplasms of Digestive Organs, Malignant Neoplasms of Female Genital Organs | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2016-09-01 | 2017-03-27 | |
| Evaluate Use of Caudal Nerve Blocks in Adult Penile Prosthesis Caudal Nerve Block (CNB), Ropivacaine, Epinephrine - Malignant Neoplasms of Male Genital Organs | Phase 3 | Completed | M.D. Anderson Cancer Center | 52 | 2016-06-01 | 2022-01-24 |
Breast Neoplasms (3) · Urologic Neoplasms (3) · Prostatic Neoplasms (1)
Neoplasms (5) · Neoplasms by Site (5) · Male Urogenital Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Breast Diseases (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Urologic Diseases (3) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Prostatic Diseases (1)
AZD 6244 (1) · Calcium Dobesilate (1) · Capecitabine (1) · Clonidine (1) · Dexamethasone (1) · Doxycycline (1) · Epinephrine (1) · MLN 8237 (1) · Neostigmine (1) · Propofol (1) · Ropivacaine (1) · Sugammadex (1) · Surveys and Questionnaires (1) · daratumumab (1) · lenvatinib (1)
M.D. Anderson Cancer Center (7)
United States (4)
Bobby Bellard, MD (1) · David S. Hong, MD (1) · Sarina Piha-Paul, MD (1) · Sarina Piha-Paul, MD, PHD (1) · Shannon Westin, MD (1) · Siqing Fu, MD, PHD (1) · Sumit K. Subudhi, MD, PHD (1)